ATA38797A - POLYMERE INFUSION SOLUTION FOR USE IN THE DIAGNOSIS OF TUMORS, IF NECESSARY FOR THEIR TREATMENT - Google Patents

POLYMERE INFUSION SOLUTION FOR USE IN THE DIAGNOSIS OF TUMORS, IF NECESSARY FOR THEIR TREATMENT

Info

Publication number
ATA38797A
ATA38797A AT0038797A AT38797A ATA38797A AT A38797 A ATA38797 A AT A38797A AT 0038797 A AT0038797 A AT 0038797A AT 38797 A AT38797 A AT 38797A AT A38797 A ATA38797 A AT A38797A
Authority
AT
Austria
Prior art keywords
polymere
tumors
diagnosis
treatment
necessary
Prior art date
Application number
AT0038797A
Other languages
German (de)
Other versions
AT409929B (en
Original Assignee
Tritthart Helmut A Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tritthart Helmut A Dr filed Critical Tritthart Helmut A Dr
Priority to AT0038797A priority Critical patent/AT409929B/en
Publication of ATA38797A publication Critical patent/ATA38797A/en
Application granted granted Critical
Publication of AT409929B publication Critical patent/AT409929B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0038797A 1997-03-07 1997-03-07 Infusion solution containing inert macromolecule becoming preferentially enriched in tumor-associated neovascularization regions, useful as carrier and targeting agent in tumor diagnosis and therapy AT409929B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0038797A AT409929B (en) 1997-03-07 1997-03-07 Infusion solution containing inert macromolecule becoming preferentially enriched in tumor-associated neovascularization regions, useful as carrier and targeting agent in tumor diagnosis and therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0038797A AT409929B (en) 1997-03-07 1997-03-07 Infusion solution containing inert macromolecule becoming preferentially enriched in tumor-associated neovascularization regions, useful as carrier and targeting agent in tumor diagnosis and therapy

Publications (2)

Publication Number Publication Date
ATA38797A true ATA38797A (en) 2002-05-15
AT409929B AT409929B (en) 2002-12-27

Family

ID=3489251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0038797A AT409929B (en) 1997-03-07 1997-03-07 Infusion solution containing inert macromolecule becoming preferentially enriched in tumor-associated neovascularization regions, useful as carrier and targeting agent in tumor diagnosis and therapy

Country Status (1)

Country Link
AT (1) AT409929B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91933A (en) * 1988-10-11 1994-12-29 Univ Southern California Vasoactive immunoconjugates useful for increasing the vascular permeability or the blood supply to neoplastic or otherwise diseased tissues
US5236694A (en) * 1990-02-21 1993-08-17 The Board Of Regents, The University Of Texas System 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents
EP0553273A4 (en) * 1990-10-16 1998-04-22 Biomed Frontiers Inc Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging

Also Published As

Publication number Publication date
AT409929B (en) 2002-12-27

Similar Documents

Publication Publication Date Title
DE69839782D1 (en) A composition containing a carrier component and a purified mycobacterial cell wall component and their use for the prevention, treatment and diagnosis of diseases
DE69834522D1 (en) High molecular flocculant, process for its preparation and process for water treatment with this agent
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
DE69929996D1 (en) PHARMACEUTICAL AGENT FOR THE TREATMENT OF DIABETES
DE69626961T2 (en) DISPOSABLE CLOTHING, METHOD AND DEVICE FOR THE PRODUCTION THEREOF
DE122007000002I1 (en) A pharmaceutical preparation for use in the treatment of diabetes.
DE69510810T2 (en) LAMANINE CHAINS: DIAGNOSTIC AND THERAPEUTIC USE
DE60023148D1 (en) AMINE AND AMIDE AS A LIGAND FOR THE NEUROPEPTIDE-Y Y5 RECEPTOR, AND ITS APPLICATION FOR THE TREATMENT OF OAT AND OTHER DISEASES
DE60233157D1 (en) TWO-CHAMBER PACEMAKER SYSTEM FOR THE DIAGNOSIS AND REMEDY OF ARRHYTHMIES
FI973183A0 (en) Contrast agents suitable for diagnostic imaging with prolonged residence in the blood
FI972287A (en) Novel types of polysubstituted DTPA derivatives and their metal complexes, pharmaceutical substances containing such complexes, their use in diagnosis and therapy, and methods for the preparation of said complexing agents and complexes and methods for their.
DE59807201D1 (en) FROM FLUID-FLOWABLE, POROUS BODY WITH THIS PULLING CHANNELS AND METHOD FOR PRODUCING THE BODY
DE60223547D1 (en) GANGLIOSID-ASSOCIATED RECOMBINANT ANTIBODIES AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF TUMORS
ATE242005T1 (en) P277 PEPTIDE ANALOGUES, PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT AND DIAGNOSIS OF DIABETES
DE3689748D1 (en) Benzimidazole derivatives, process for their preparation and their therapeutic use.
DE69735785D1 (en) Drug for clogging blood vessels of the fundus
DE58905246D1 (en) HETEROCYCLIC SUBSTITUTED ALKOXYCUMARINES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC AGENTS CONTAINING THEM.
KR950700726A (en) Composition for treatment or diagnosis, its manufacturing method and use (COMPOSITION FOR THERAPEUTIC OR DIAGNOSTIC USE, PROCESS FOR ITS PREPARATION AND ITS USE)
DE60032956D1 (en) Ion-selective membranes, processes for their preparation, use of ion-selective membranes and devices containing ion-selective membranes
DE69838785D1 (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CEREBRAL AMYLOIDOSIS
DE60204755D1 (en) "3,7-DIAZABICYCLO (3.3.0) OCTANE AND ITS USE IN THE TREATMENT OF CARDIAC ERRORS"
DE69829217D1 (en) DEVICE FOR THE THERAPEUTIC TREATMENT OF BLOOD VESSELS
ID16989A (en) 2-NAFTOILGUANIDIN SUBSTITUTED, THE PROCESS FOR MAKING IT, USE IT AS A DRUG OR DIAGNOSTIC, AND THE DRUGS CONTAINING IT
DE69721719T2 (en) Surgical needle, process for its preparation, and needle holder
DE58904595D1 (en) NEW ALKYLPHOSPHONOSERINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENT CONTAINING IT.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee